Valeo Financial Advisors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-120
Closed -$3K 720
2021
Q1
$3K Hold
120
﹤0.01% 1685
2020
Q4
$3K Hold
120
﹤0.01% 1454
2020
Q3
$3K Hold
120
﹤0.01% 1332
2020
Q2
$2K Sell
120
-101
-46% -$1.28K ﹤0.01% 1733
2020
Q1
$2K Hold
221
﹤0.01% 1493
2019
Q4
$4K Sell
221
-100
-31% -$1.66K ﹤0.01% 1329
2019
Q3
$5K Sell
321
-80
-20% -$1.3K ﹤0.01% 1187
2019
Q2
$10K Hold
401
﹤0.01% 1016
2019
Q1
$15K Buy
401
+20
+5% +$728 ﹤0.01% 856
2018
Q4
$11K Sell
381
-60
-14% -$1.9K ﹤0.01% 852
2018
Q3
$14K Hold
441
﹤0.01% 865
2018
Q2
$20K Buy
441
+50
+13% +$2.49K ﹤0.01% 758
2018
Q1
$19K Hold
391
﹤0.01% 728
2017
Q4
$20K Hold
391
﹤0.01% 661
2017
Q3
$20K Buy
+391
New +$18.4K ﹤0.01% 551

Other funds holding CC

Valeo Financial Advisors's CC Position: Q2 2021 in Review

Valeo Financial Advisors sold out of Chemours (CC) in Q2 2021, closing a stake of 120 shares — an estimated $3K sold.

Valeo Financial Advisors first reported a position in CC in Q3 2017 and held it in 15 quarters. The position peaked at $20K in Q2 2018. 449 funds tracked by Wall St. Rank hold CC as of Q2 2021.

  • Valeo Financial Advisors reported no remaining Chemours position as of Q2 2021 after selling out during the quarter.
  • Valeo Financial Advisors sold 120 Chemours shares in Q2 2021, an estimated $3K.
  • Valeo Financial Advisors first reported a position in Chemours in Q3 2017 and held it in 15 quarters.
  • Valeo Financial Advisors's Chemours position peaked at $20K in Q2 2018.
  • 449 funds tracked by Wall St. Rank held Chemours as of Q2 2021.

Based on Valeo Financial Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.